about
microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R.Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck.Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes.Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.A new hypothesis for the cancer mechanism.Transaminase Activity Predicts Survival in Patients with Head and Neck CancerThe use of salivary cytokines as a screening tool for oral squamous cell carcinoma : A review of the literatureSerum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer.Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients.Rapamycin targets Interleukin 6 (IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells.Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: A meta-analysis.Tumor-produced, active interleukin-1β regulates gene expression in carcinoma-associated fibroblasts.Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma.Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.Increased expression of the prolactin receptor is associated with malignant laryngeal tumors.Prognostic utility of autoantibodies to α-enolase and Hsp70 for cancer of the gingivo-buccal complex using immunoproteomics.Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma.Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.Survivin-Based Treatment Strategies for Squamous Cell Carcinoma.Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients.Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients.
P2860
Q34120352-0254CC84-45C4-485E-BCE4-0137B40B3E25Q34568232-7DD14723-217B-40A5-AE4D-FE129219F2B4Q35006785-65D6CDD5-6349-4DB6-8593-7E8BD2222B96Q35123145-54D8EF2E-0683-4575-A85E-F4687958325FQ35342995-3A22B66A-6C2B-4D77-BF81-9488DEBB333CQ35673572-788613B4-36E3-4310-9F60-CB8CBB2800DBQ35954093-7B472F61-C26E-45EC-BD39-705B24EACC29Q36161469-C95994EC-591F-4073-B1E0-F560072B7810Q36181187-25352A3B-DB3C-4EC7-8560-ADCFEF2A51D6Q36293419-67B07CF7-6C37-4E12-B16A-AB6D07234FDAQ36397375-5B43CB59-0D48-4A88-8A19-82BF10468743Q37024656-C56756DC-560D-4ED9-AD79-5C2FABD29072Q37448156-B02E4600-0DF1-423E-B406-777753838FB6Q38044324-A75A096B-3577-4DD1-8DDC-07F7030EA184Q38373360-97469255-794D-48EC-8A9D-9D069102D17FQ39193688-3C9AF56F-228A-4105-A1A1-7D9F83771387Q39612090-4F56E288-ACCA-415D-B000-BFD0199A3E92Q42081560-343BDD94-1351-4CAB-AC5D-F057ECE84C56Q44159554-1339ADEF-A381-470A-8EC3-A45367986E5CQ44554262-31C64E2B-BE7B-499E-A8D5-CC9D3AF548FAQ47988612-51A3EDCB-3388-4641-9931-855EA430E2BAQ51758973-1C925033-6AA9-47F5-BDA1-605AAB47CA54Q55058835-066FBC79-2897-4D40-AAA4-5B0C3C551EA2Q55280852-52C82455-7EC6-4FAE-8EE9-762715FFBD49Q55312802-6501DF01-22F8-422E-994F-0456AD4AF8E4
P2860
description
im Januar 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2010
@uk
name
Serum Prognostic Markers in Head and Neck Cancer
@en
Serum Prognostic Markers in Head and Neck Cancer
@nl
type
label
Serum Prognostic Markers in Head and Neck Cancer
@en
Serum Prognostic Markers in Head and Neck Cancer
@nl
prefLabel
Serum Prognostic Markers in Head and Neck Cancer
@en
Serum Prognostic Markers in Head and Neck Cancer
@nl
P2093
P1476
Serum Prognostic Markers in Head and Neck Cancer
@en
P2093
I. Bairati
P. Douville
T. Duchesne
P304
P356
10.1158/1078-0432.CCR-09-2014
P407
P50
P577
2010-01-26T00:00:00Z